Pharmabiz

India poised to emerge as global pharma innovation hub: DCGI

India is steadily strengthening its position as a global pharmaceutical innovation and manufacturing hub, backed by its ...
Pharmabiz

UV radiation can damage DNA in skin cells and contribute to skin cancer, cautions Dr Saptarshi Ghosh

UV radiation can damage DNA in skin cells and contribute to skin cancer, cautions Dr Saptarshi Ghosh: Our Bureau, Mumbai Monday, November 9, 2026, 17:20 Hrs [IST] Ultraviolet radi ...
Pharmabiz

J&J reports positive results from phase 3 study of Icotyde in biologic-naïve adults with active psoriatic arthritis

J&J reports positive results from phase 3 study of Icotyde in biologic-naïve adults with active psoriatic arthritis: New Brunswick, New Jersey Monday, November 9, 2026, 18:00 Hrs ...
Pharmabiz

PumasAI releases Pumas 2.9 with advanced scientific modelling and simulation for better clinical pharmacology and pharmacometrics performance

PumasAI releases Pumas 2.9 with advanced scientific modelling and simulation for better clinical pharmacology and pharmacometrics performance: Dover, Delaware Monday, November 9, ...
Pharmabiz

WHO invites feedback on a draft target product profile for wearable devices to measure physical activity and sedentary behaviour in population health monitoring systems

WHO invites feedback on a draft target product profile for wearable devices to measure physical activity and sedentary behaviour in population health monitoring systems: Geneva Mo ...
Pharmabiz

J&J announces new phase 2 nipocalimab study data in Sjögren’s disease that reveal insights on importance of symptom improvements most valued by patients

J&J announces new phase 2 nipocalimab study data in Sjögren’s disease that reveal insights on importance of symptom improvements most valued by patients: New Brunswick, New Jer ...
Pharmabiz

Morepen Laboratories launches desloratadine tablets in US market

Morepen Laboratories launches desloratadine tablets in US market: Our Bureau, Mumbai Monday, November 9, 2026, 17:10 Hrs [IST] Morepen Laboratories Limited announced the launch of ...
Pharmabiz

85 cos report revised price of 1,364 anticancer formulations till Nov 8 following imposition of TMR

Trade Margin Rationalisation (TMR) on anti-cancer drugs came into effect from November 9, the Authority has announced that 85 pharmaceutical companies have reported revised maximum retail price (MRP) ...
Pharmabiz

New partnership will expand research opportunities at Duke

Duke University School of Medicine’s newly announced partnership with industry will give researchers the ability to develop models to discover new therapies, match patients to the right therapies, and ...
Pharmabiz

Kos Biotechnology Partners announces investment in Fathom Therapeutics to advance novel, AI-driven drug discovery platform

Kos Biotechnology Partners announces investment in Fathom Therapeutics to advance novel, AI-driven drug discovery platform: New York Monday, November 9, 2026, 11:00 Hrs [IST] Kos ...
Pharmabiz

Two ‘forever chemicals’ associated with higher risk of aggressive breast cancer in NIH analysis

Two ‘forever chemicals’ associated with higher risk of aggressive breast cancer in NIH analysis: Bethesda, Maryland Monday, November 9, 2026, 12:00 Hrs [IST] Women with higher ...
Pharmabiz

DGFT mandates continuous tracking of pharma export quality complaints through Indian missions

DGFT mandates continuous tracking of pharma export quality complaints through Indian missions: Shardul Nautiyal, Mumbai Monday, November 9, 2026, 08:00 Hrs [IST] The Directorate G ...